Alphaherpesvirus vaccines

Clare Burn Aschner, Betsy C. Herold

Research output: Contribution to journalArticlepeer-review

Abstract

Prophylactic and therapeutic vaccines for the alphaherpesviruses including varicella zoster virus (VZV) and herpes simplex virus types 1 and 2 have been the focus of enormous preclinical and clinical research. A live viral vaccine for prevention of chickenpox and a subunit therapeutic vaccine to prevent zoster are highly successful. In contrast, progress towards the development of effective prophylactic or therapeutic vaccines against HSV-1 and HSV-2 has met with limited success. This review provides an overview of the successes and failures, the different types of immune responses elicited by various vaccine modalities, and the need to reconsider the preclinical models and immune correlates of protection against HSV.

Original languageEnglish (US)
Pages (from-to)469-508
Number of pages40
JournalCurrent Issues in Molecular Biology
Volume41
DOIs
StatePublished - 2021

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology
  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Alphaherpesvirus vaccines'. Together they form a unique fingerprint.

Cite this